Ajax Therapeutics is a biotechnology company focused on developing novel therapies for myelofibrosis and polycythemia vera. In 2026, Eli Lilly announced the acquisition of Ajax Therapeutics to advance outcomes for patients with these serious blood disorders, integrating Ajax’s pipeline into Lilly’s broader research portfolio.
Ajax Therapeutics publishes 1 API on the APIs.io network. Tagged areas include Company, Biotechnology, Therapeutics, Myelofibrosis, and Polycythemia Vera.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: ajak-therapeutics
name: Ajax Therapeutics
description: Ajax Therapeutics is a biotechnology company focused on developing novel therapies for myelofibrosis and polycythemia
vera. In 2026, Eli Lilly announced the acquisition of Ajax Therapeutics to advance outcomes for patients with these serious
blood disorders, integrating Ajax’s pipeline into Lilly’s broader research portfolio.
url: https://raw.githubusercontent.com/api-evangelist/ajak-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-09-23 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-09-23'
modified: '2026-09-23'
tags:
- Company
- Biotechnology
- Therapeutics
- Myelofibrosis
- Polycythemia Vera
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/ajak-therapeutics-hosts.yml
- type: Vendors
url: vendors/ajak-therapeutics-vendors.yml
- type: DomainSecurity
url: security/ajak-therapeutics-domain-security.yml
- type: Website
url: https://www.lilly.com/science/subsidiaries
apis:
- name: Ajax Therapeutics API
description: Ajax Therapeutics does not expose a public API; no documentation host or machine‑readable specification was
found.
humanURL: https://www.lilly.com/science/subsidiaries
aid: ajak-therapeutics:ajax-therapeutics-api
x-coverage:
state: unreadable
reason: no-machine-readable-spec
detail: The provider's website returns no machine‑readable API specification and no documentation host was discovered.
evidence:
- url: https://www.ajaxtherapeutics.com/
status: 405
checked: 2026-09-23
x-enrichment:
date: '2026-09-23'
status: enriched
artifacts_added: 5
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →